Icon (ICLR) Notes Payables (2023 - 2024)
Icon's (ICLR) quarterly Notes Payables came in at $4.9 billion in Q1 2024, up 6.49% quarter-over-quarter from $4.6 billion in Q4 2023.
Powered by 
Analysis
Icon (ICLR) Notes Payables (2023 - 2024) Analysis & Trends
Icon (ICLR) has reported Notes Payables for 2 consecutive years, with $4.9 billion the latest figure, recorded in Q1 2024.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $4.9 billion in Q1 2024; TTM through Mar 2024 was $4.9 billion, a N/A change from a year earlier, with the FY2023 full-year figure at $4.6 billion, changed N/A from the prior year.
- Notes Payables was $4.9 billion for Q1 2024 at Icon, up from $4.6 billion in the prior quarter.
- Over five years, Notes Payables peaked at $4.9 billion in Q1 2024 and troughed at $4.6 billion in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |